EN DE
Watch Rede D'Or São Luiz S.A. for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Rede D'Or São Luiz S.A. (RDOR3) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of Rede D'Or São Luiz S.A. stock BRL 47.47, price BRL 32.67, upside +45.3%, quality 51 out of 100. Rating: undervalued. Calculated from audited financials with 17 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare BR · ISIN BRRDORACNOR8

RD Rede D'Or São Luiz S.A. logo Broad data Nov 3, 2026

Rede D'Or São Luiz S.A.

RDOR3 · SA
Meets all rules: undervalued, solid quality, uptrend

The stock costs 31% less than our calculation considers fair.

Fair value R$47.47 · Undervalued (31%)
Ranks above peers (9/13)
Broad data
Even on cautious assumptions the value is 9% above the price (R$35.61).
Quality 51/100
Expensive Growth (revenue 5y +31.8 %/yr in BRL)
Thin margins · 8.4% net margin (TTM)
Moderate moat 57/100 · thin data
High debt
Negative free cash flow
12.0% dividend yield · Pays more than it earns

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

R$63.35 R$17.12 Fair Value R$47.47 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 3, 2026.

How to read this chart

60‑month range R$17.12 – R$63.35 · fair‑value band R$35.61 – R$59.34 · the R$32.67 price screens below the R$47.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 3, 2026.

Follow Rede D'Or São Luiz in your weekly email

Every Wednesday you see whether Rede D'Or São Luiz is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Rede D'Or São Luiz S.A. engages in the provision of hospital services in Brazil. The company provides assistance and hospitality concept services; and supplementary services, such as blood bank, dialysis, and outpatient clinics with various specialties.

Show moreShow less

It also offers health insurance and plan, as well as dental plans for small, medium, and large-sized companies; individual plans; individual and group life, travel, credit life, endowment, as well as personal, individual, and group accident insurance products; and pension risk.

In addition, the company owns and operates hospitals, and oncology and radiotherapy clinics and laboratories. Further, it is involved in asset management activities.

The company was formerly known as Hospital Maternidade São Luiz S.A. Rede D'Or São Luiz S.A. was founded in 1977 and is headquartered in São Paulo, Brazil.

Stock analysis

Rede D'Or São Luiz S.A. (RDOR3) currently trades at R$32.67, while our model-based Fair Value estimate is R$47.47, implying the stock looks roughly 31% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of R$162.43 per share, and 12 of the 17 models we run sit above the R$32.67 price.

Bear case: the Economic Profit group reads lowest at R$13.85, and 5 of the 17 models stay below the price. Data coverage for this calculation is high.

Scenario range: R$35.61 (bear) to R$59.34 (bull), the price of R$32.67 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 51/100 (solid quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Rede D'Or São Luiz S.A. reported revenue of R$55.7B in FY2025 versus R$20.4B in FY2021, a compound +28.6%/yr. Reported net income was R$4.7B in FY2025, compounding +31.3%/yr from FY2021.

Key figures

Market cap R$71.1B (≈ $13.0B) Large · P/E ratio 14.9 · P/S ratio 1.23 · EPS (TTM) R$2.20 · Dividend yield 12.0% · Net margin 8.4% · Return on equity 19.8% · Return on assets (EBIT) 6.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 57 out of 100 (low confidence).

What moves the price

The share trades about 29% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at 45%, RDOR3 screens cheaper than that median.

Fair Value models

Bear R$35.61 Fair Value R$47.47 Bull R$59.34
Price R$32.67 · Upside +45.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income R$11.46 R$13.85 R$19.88 75
EPV R$13.98 R$18.42 R$22.12 74
Owner Earnings R$68.86 R$162.43 R$335.54 71
All 17 models by family
DCF Models
Owner Earnings R$68.86 R$162.43 R$335.54 71
Earnings-Based
Graham-Dodd R$14.67 R$102.33 R$143.61 63
Lynch FV R$33.26 R$47.52 R$61.77 61
PEG = 1.0 R$33.26 R$47.52 R$61.77 57
EPV R$13.98 R$18.42 R$22.12 74
Dividend Discount
Gordon GGM R$23.35 R$41.94 R$57.56 68
DDM Multi-Stage R$23.35 R$38.38 R$44.81 67
Multiples
P/E Multiple R$35.61 R$47.47 R$59.34 63
P/S Multiple R$27.51 R$36.69 R$45.86 58
P/B Multiple R$5.50 R$7.34 R$9.17 55
EV/EBIT R$36.24 R$55.87 R$75.50 65
EV/EBITDA R$46.08 R$68.99 R$91.90 66
EV/Revenue R$19.38 R$37.39 R$55.40 51
Asset-Based
NCAV (Graham) R$0.8200 R$1.09 R$1.63 54
Economic Profit
Residual Income R$11.46 R$13.85 R$19.88 75
ROIC Compounder R$17.62 R$30.94 R$40.35 71
Growth Earnings
Growth-Adj P/E R$45.09 R$64.42 R$83.74 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 51/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 44
How much profit the company makes from its sales and capital
Quality Growth 60
Are margins and returns getting better?
Cashflow 5
Do the profits arrive as real cash?
Financial strength 18
Debt, balance sheet and risk of trouble
Investment 82
Does it invest with discipline instead of growing at any price?
Low Volatility 64
How calm the share price moves, does not count
Price momentum 37
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 13
Distance to the 52-week high, does not count
New shares 93
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+10.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+34.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.8%
Start year 2020 (pandemic). Over 10 years: +24.1% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.2%
What shareholders gained per year (last 5 years), in BRL (mathematically smoothed) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Smoothed = median of all growth paths between the years of the window (trend line on the logarithm of earnings per share): a single extreme year cannot distort the rate. The reported figure stays in the tooltip. Measured in BRL: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+69.4%
Earnings growth per share plus dividend.
Earnings per share, growth per year+57.4%
Dividend (yield on the price)12.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.26.4% vs 9.9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 18%
2025 sits 135% above its own trend. The rate follows the median trend of the last 5 years, not that single year.
Pace: the 5-year rate starts in 2020 (pandemic)

Watch RDOR3, get fair value alerts →

Note from the team Nov 3, 2026
AI conclusion: The business gains from its shift into complex surgeries and oncology with rising margins, yet is held back by negative free cash flow and high leverage.
Main risk: Payer dynamics could limit gains from the service mix shift and thereby pressure earnings quality along with margins.
Rede D'Or is moving beyond simple bed additions toward more complex surgeries and oncology, where higher average tickets and margins are already showing in recent quarters. Cash conversion remains robust even with measured overall growth. Our models see the shares as undervalued, but will the mix shift accelerate earnings quality gains faster than investors expect or will payer dynamics cap the upside?
Join the discussion →

Compare Rede D'Or São Luiz S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 235 stocks

Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 51 · Below median
Fair Value upside +45.3% · Above median
Profitability
Return on equity (12 months) 19.8% · Top 25%
Return on assets 4.4% · Above median
Net margin (12 months) 8.4% · Above median
Operating margin (12 months) 19.0% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 5.0% · Below median
Dividend yield (12 months) 12.0% · Top 25%
Balance sheet
Debt / equity 2.30× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 14.9× · Cheaper than median
P/B 3.67× · Priciest 25%
P/S (12 months) 1.23× · Cheaper than median
EV/EBITDA 8.9× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)94 · sector 35
FUTURE (revenue growth)25 · sector 29
PAST (return on equity)79 · sector 33
HEALTH (low debt)0 · sector 90
DIVIDEND (yield)100 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Aier Eye Hospital Group 300015 ¥8.99 ¥10.88 +21% vs RDOR3
DaVita Inc DVA $194.82 $218.90 +12% vs RDOR3
HCA Healthcare, Inc HCA $507.48 $547.34 +8% vs RDOR3
Tenet Healthcare Corporation THC $286.46 $279.20 −3% vs RDOR3
Fresenius Medical Care AG FME €42.32 €39.20 −7% vs RDOR3
The Ensign Group ENSG $182.39 $140.09 −23% vs RDOR3
Encompass Health Corporation EHC $141.27 $94.81 −33% vs RDOR3
Fresenius SE FRE €51.87 €34.56 −33% vs RDOR3
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,371 ₹5,234 −37% vs RDOR3
Dr. Sulaiman Al Habib Medical Services Group 4013 215.80 SAR 109.45 SAR −49% vs RDOR3

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Rede D'Or São Luiz S.A.: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Rede D'Or São Luiz S.A. Fair Value". https://www.fairvalue-calculator.com/stock/RDOR3

Frequently asked questions

Is Rede D'Or São Luiz S.A. (RDOR3) overvalued or undervalued?
As of Nov 3, 2026, our model estimates a fair value of R$47.47 versus a price of R$32.67, about +45% upside (undervalued).
What is the fair value of RDOR3?
Our model-based fair value for Rede D'Or São Luiz S.A. is R$47.47 (as of Nov 3, 2026), built from audited fundamentals. The current price: R$32.67.
What is the quality score of RDOR3?
Rede D'Or São Luiz S.A. has a Quality Score of 51/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Rede D'Or São Luiz S.A. (RDOR3)?
Our model-based price target is the fair value of R$47.47 (as of Nov 3, 2026) from 17 valuation models. Cautious scenario R$35.61, optimistic scenario R$59.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Rede D'Or São Luiz S.A. stock forecast for 2026?
Our models put fair value at R$47.47, about +45% upside versus a price of R$32.67 (undervalued). Cautious scenario R$35.61, optimistic scenario R$59.34. The calculation is refreshed regularly with new filings.
What is the revenue of Rede D'Or São Luiz S.A. (RDOR3)?
Rede D'Or São Luiz S.A. reported trailing-twelve-month revenue of about R$57.8B (latest available figure, as of Nov 3, 2026).
Does Rede D'Or São Luiz S.A. pay a dividend?
Rede D'Or São Luiz S.A. currently shows a dividend yield of 11.96% relative to its recent price (as of Nov 3, 2026).
What is the intrinsic value of Rede D'Or São Luiz S.A. (RDOR3)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Rede D'Or São Luiz S.A. it is R$47.47 per share (as of Nov 3, 2026), against a price of R$32.67. It is the blended result of 17 valuation models (cash flow, earnings, asset, dividend).
Is Rede D'Or São Luiz S.A. stock overvalued or undervalued in 2026?
As of Nov 3, 2026, RDOR3 trades below its calculated fair value: price R$32.67, fair value R$47.47, a gap of about +45% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RDOR3?
No. The price is what the market pays today (R$32.67); the fair value is what the company's own numbers justify (R$47.47). For Rede D'Or São Luiz S.A. the two are R$14.80 per share apart. That gap is exactly why we show both numbers side by side.
How much is Rede D'Or São Luiz S.A. worth?
The market values Rede D'Or São Luiz S.A. at about R$71.1B (market capitalisation, as of Nov 3, 2026). Per share that is R$32.67; our models calculate a fair value of R$47.47 per share.
What do the bullish and bearish scenarios say about RDOR3?
Our models span a range for Rede D'Or São Luiz S.A.: cautious scenario R$35.61, base R$47.47, optimistic R$59.34 per share (as of Nov 3, 2026, price R$32.67). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of RDOR3?
Rede D'Or São Luiz S.A. trades at a price-to-earnings ratio of 14.9 (as of Nov 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of R$47.47 is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2020 to 2025), reported earnings: 43.8. Other multiples: P/B 3.7, P/S 1.2, EV/EBITDA 8.9.
How solid is the balance sheet of Rede D'Or São Luiz S.A. (RDOR3)?
Balance-sheet figures for Rede D'Or São Luiz S.A. (as of Nov 3, 2026): return on equity 19.8%, debt of 2.30 per unit of equity. They feed the Quality Score of 51/100, which measures business quality independently of the share price.
How far is RDOR3 from its 52-week high?
Rede D'Or São Luiz S.A. trades at R$32.67, about 29% below its 52-week high of R$45.75 and 4% above the low of R$31.29 (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of R$47.47 is for.
Which stocks are comparable to Rede D'Or São Luiz S.A.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Rede D'Or São Luiz S.A. stock attractive at the current price?
The data as of Nov 3, 2026: price R$32.67, calculated fair value R$47.47 (+45%), Quality Score 51/100, from 17 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RDOR3 calculated?
We run Rede D'Or São Luiz S.A. through 17 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of R$47.47, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.5% above its aggregate fair value. Rede D'Or São Luiz S.A. currently trades 31% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Rede D'Or São Luiz S.A. (RDOR3)?
The closing price on Nov 5, 2026 was R$32.67. Our model-based fair value is R$47.47, about +45% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Rede D'Or São Luiz S.A. right now?
The price is below even our cautious bear case (R$35.61). The market is more pessimistic than our downside scenario. Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Rede D'Or São Luiz S.A. (RDOR3) come from?
Earnings per share at Rede D'Or São Luiz S.A. grew +8.6 % a year from 2014 to 2025. Broken into its drivers: revenue per share +12.6 %, EBIT margin −2.9 %, tax rate +0.9 %, residual (interest, one-offs) −1.5 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Rede D'Or São Luiz S.A.

How large is the market capitalisation of Rede D'Or São Luiz S.A. (RDOR3)?
The market capitalisation of Rede D'Or São Luiz S.A. is R$71.1B (≈ $13.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Rede D'Or São Luiz S.A. (RDOR3)?
The price-to-sales ratio of Rede D'Or São Luiz S.A. is 1.23 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Rede D'Or São Luiz S.A. (RDOR3)?
Earnings per share at Rede D'Or São Luiz S.A. are R$2.20 (price ÷ EPS = P/E 14.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Rede D'Or São Luiz S.A. (RDOR3)?
The dividend yield of Rede D'Or São Luiz S.A. is 12.0% (payout 178%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Rede D'Or São Luiz S.A. (RDOR3)?
The net margin of Rede D'Or São Luiz S.A. is 8.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Rede D'Or São Luiz S.A. (RDOR3)?
The return on equity (ROE) of Rede D'Or São Luiz S.A. is 19.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Rede D'Or São Luiz S.A. (RDOR3)?
On an EBIT basis the return on assets of Rede D'Or São Luiz S.A. is 6.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Rede D'Or São Luiz S.A. (RDOR3)?
The operating margin of Rede D'Or São Luiz S.A. is 19.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Rede D'Or São Luiz S.A. (RDOR3)?
Revenue at Rede D'Or São Luiz S.A. is growing +5.0% versus a year earlier (3y avg +34.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Rede D'Or São Luiz S.A. (RDOR3)?
Earnings per share at Rede D'Or São Luiz S.A. are growing +22.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Rede D'Or São Luiz S.A. (RDOR3) generate?
The free cash flow of Rede D'Or São Luiz S.A. is −R$2.4B (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Rede D'Or São Luiz S.A. (RDOR3) carry?
The net debt of Rede D'Or São Luiz S.A. is R$49.2B (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Rede D'Or São Luiz S.A. in the live analysis

One click puts Rede D'Or São Luiz S.A. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.